Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
This office will be the central hub for all operations related to companies ethical pharmaceutical business
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
Subscribe To Our Newsletter & Stay Updated